ID   ISO-HAS
AC   CVCL_C516
SY   ISO HAS
DR   IARC_TP53; 12979
DR   JCRB; IFO50514
DR   RCB; RCB3674
DR   TKG; TKG 0593
DR   Wikidata; Q54898319
RX   PubMed=10188735;
RX   PubMed=12453433;
CC   Population: Japanese.
CC   Doubling time: 64 hours (PubMed=10188735).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser240Arg (c.720T>A); ClinVar=VCV001504304; Zygosity=Unspecified (PubMed=10188735).
CC   Discontinued: JCRB; IFO50514; true.
CC   Discontinued: RCB; RCB3674; true.
CC   Derived from site: Metastatic; Ear, skin; UBERON=UBERON_0001459.
ST   Source(s): TKG=TKG 0593
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4489; Skin angiosarcoma
DI   ORDO; Orphanet_263413; Angiosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
RX   PubMed=10188735; DOI=10.1002/(SICI)1097-0215(19990412)81:2<305::AID-IJC22>3.0.CO;2-Z;
RA   Masuzawa M., Fujimura T., Hamada Y., Fujita Y., Hara H., Nishiyama S.,
RA   Katsuoka K., Tamauchi H., Sakurai Y.;
RT   "Establishment of a human hemangiosarcoma cell line (ISO-HAS).";
RL   Int. J. Cancer 81:305-308(1999).
//
RX   PubMed=12453433; DOI=10.1006/mvre.2002.2434;
RA   Unger R.E., Krump-Konvalinkova V., Peters K., Kirkpatrick C.J.;
RT   "In vitro expression of the endothelial phenotype: comparative study
RT   of primary isolated cells and cell lines, including the novel cell
RT   line HPMEC-ST1.6R.";
RL   Microvasc. Res. 64:384-397(2002).
//